Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

A unit increase in the BMI of visceral leishmaniasis patients increases the serum vitamin D level by 1.52 ng/ml.

Source: Interpretations. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Micronutrient levels and their effects on the prognosis of visceral leishmaniasis treatment, a prospective cohort study

Source: Article title.

From these treatment centers, more than 5000 incident visceral leishmaniasis patients was reported annually [, ].

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Micronutrient levels and their effects on the prognosis of visceral leishmaniasis treatment, a prospective cohort study

Cohort study · BMC Infectious Diseases · 2020

Original publication title

Micronutrient levels and their effects on the prognosis of visceral leishmaniasis treatment, a prospective cohort study

Berhanu Elfu Feleke; Teferi Elfu Feleke

© The Author(s) 2020

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The micronutrient levels of visceral leishmaniasis patients were significantly lower. The anti-leishmaniasis treatment did not increase the serum micronutrient level of the patients.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Micronutrients are minerals and vitamins and they are essential for normal physiological activities. The objectives of the study were to describe the progress and determinants of micronutrient levels and to assess the effects of micronutrients in the treatment outcome of kalazar.

Source: Background

Abstract: What methods does the paper describe?

A prospective cohort study design was used. The data were collected using patient interviews, measuring anthropometric indicators, and collecting laboratory samples. The blood samples were collected at five different periods during the leishmaniasis treatments: before starting anti-leishmaniasis treatments, in the first week, in the second week, in the third week, and in the 4th week of anti-leishmaniasis treatments. Descriptive statistics were used to describe the profile of patients and to compare the treatment success rate. The generalized estimating equation was used to identify the determinants of serum micronutrients.

Source: Methods

Abstract: Results

The mean age of the patients were 32.88 years [SD (standard deviation) ±15.95]. Male constitute 62.3% of the patients and problematic alcohol use was present in 11.5% of the patients. The serum zinc level of visceral leishmaniasis patients was affected by alcohol (B − 2.7 [95% CI: − 4.01: -1.5]), DDS (B 9.75 [95% CI: 7.71 to 11.79]), family size (B -1.63 [95% CI: − 2.68: -0.58]), HIV (B -2.95 [95% CI: − 4.97: -0.92]), and sex (B − 1.28 [95% CI: − 2.5: -0.07]).

The serum iron level of visceral leishmaniasis patients was affected by alcohol (B 7.6 [95% CI: 5.86 to 9.35]), family size (B -5.14 [95% CI: − 7.01: -3.28]), malaria (B -12.69 [95% CI: − 14.53: -10.87]), Hookworm (− 4.48 [− 6.82: -2.14]), chronic diseases (B -7.44 [95% CI: − 9.75: -5.13]), and HIV (B -5.51 [95% CI: − 8.23: -2.78]). The serum selenium level of visceral leishmaniasis patient was affected by HIV (B -18.1 [95% CI: − 20.63: -15.58]) and family size (B -11.36 [95% CI: − 13.02: -9.7]).

The iodine level of visceral leishmaniasis patient was affected by HIV (B -38.02 [95% CI: − 41.98: -34.06]), DDS (B 25 .84 [95% CI: 22.57 to 29.1]), smoking (B -12.34 [95% CI: − 15.98: -8.7]), chronic illness (B -5.14 [95% CI: − 7.82: -2.46]), and regular physical exercise (B 5.82 [95% CI: 0.39 to 11.26]). The serum vitamin D level of visceral leishmaniasis patient was affected by HIV (B -9.43 [95% CI: − 10.92: -7.94]), DDS (B 16.24 [95% CI: 14.89 to 17.58]), malaria (B -0.61 [95% CI: − 3.37: -3.37]), and family size (B -1.15 [95% CI: − 2.03: -0.28]).

The serum vitamin A level of visceral leishmaniasis patient was affected by residence (B 0.81 [95% CI: 0.08 to 1.54]), BMI (B 1.52 [95% CI: 0.42 to 2.6]), DDS (B 1.62 [95% CI: 0.36 to 2.88]), family size (B -5.03 [95% CI: − 5.83: -4.22]), HIV (B -2.89 [95% CI: − 4.44: -1.34]),MUAC (B 0.86 [95% CI: 0.52 to 1.21]), and age (B 0.09 [95% CI: 0.07 to 0.12]).

Source: Results

Abstract: Conclusion

The micronutrient levels of visceral leishmaniasis patients were significantly lower. The anti-leishmaniasis treatment did not increase the serum micronutrient level of the patients.

Source: Conclusion
Authors’ abstract

Background

Micronutrients are minerals and vitamins and they are essential for normal physiological activities. The objectives of the study were to describe the progress and determinants of micronutrient levels and to assess the effects of micronutrients in the treatment outcome of kalazar.

Methods

A prospective cohort study design was used. The data were collected using patient interviews, measuring anthropometric indicators, and collecting laboratory samples. The blood samples were collected at five different periods during the leishmaniasis treatments: before starting anti-leishmaniasis treatments, in the first week, in the second week, in the third week, and in the 4th week of anti-leishmaniasis treatments. Descriptive statistics were used to describe the profile of patients and to compare the treatment success rate. The generalized estimating equation was used to identify the determinants of serum micronutrients.

Results

The mean age of the patients were 32.88 years [SD (standard deviation) ±15.95]. Male constitute 62.3% of the patients and problematic alcohol use was present in 11.5% of the patients. The serum zinc level of visceral leishmaniasis patients was affected by alcohol (B − 2.7 [95% CI: − 4.01: -1.5]), DDS (B 9.75 [95% CI: 7.71 to 11.79]), family size (B -1.63 [95% CI: − 2.68: -0.58]), HIV (B -2.95 [95% CI: − 4.97: -0.92]), and sex (B − 1.28 [95% CI: − 2.5: -0.07]).

The serum iron level of visceral leishmaniasis patients was affected by alcohol (B 7.6 [95% CI: 5.86 to 9.35]), family size (B -5.14 [95% CI: − 7.01: -3.28]), malaria (B -12.69 [95% CI: − 14.53: -10.87]), Hookworm (− 4.48 [− 6.82: -2.14]), chronic diseases (B -7.44 [95% CI: − 9.75: -5.13]), and HIV (B -5.51 [95% CI: − 8.23: -2.78]). The serum selenium level of visceral leishmaniasis patient was affected by HIV (B -18.1 [95% CI: − 20.63: -15.58]) and family size (B -11.36 [95% CI: − 13.02: -9.7]).

The iodine level of visceral leishmaniasis patient was affected by HIV (B -38.02 [95% CI: − 41.98: -34.06]), DDS (B 25 .84 [95% CI: 22.57 to 29.1]), smoking (B -12.34 [95% CI: − 15.98: -8.7]), chronic illness (B -5.14 [95% CI: − 7.82: -2.46]), and regular physical exercise (B 5.82 [95% CI: 0.39 to 11.26]). The serum vitamin D level of visceral leishmaniasis patient was affected by HIV (B -9.43 [95% CI: − 10.92: -7.94]), DDS (B 16.24 [95% CI: 14.89 to 17.58]), malaria (B -0.61 [95% CI: − 3.37: -3.37]), and family size (B -1.15 [95% CI: − 2.03: -0.28]).

The serum vitamin A level of visceral leishmaniasis patient was affected by residence (B 0.81 [95% CI: 0.08 to 1.54]), BMI (B 1.52 [95% CI: 0.42 to 2.6]), DDS (B 1.62 [95% CI: 0.36 to 2.88]), family size (B -5.03 [95% CI: − 5.83: -4.22]), HIV (B -2.89 [95% CI: − 4.44: -1.34]),MUAC (B 0.86 [95% CI: 0.52 to 1.21]), and age (B 0.09 [95% CI: 0.07 to 0.12]).

Conclusion

The micronutrient levels of visceral leishmaniasis patients were significantly lower. The anti-leishmaniasis treatment did not increase the serum micronutrient level of the patients.

Publication and source details

Original title: Micronutrient levels and their effects on the prognosis of visceral leishmaniasis treatment, a prospective cohort study

Berhanu Elfu Feleke; Teferi Elfu Feleke

BMC Infectious Diseases · 2020

© The Author(s) 2020https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.http://dx.doi.org/10.13039/501100005872Bahir Dar UniversityMinistry of health, Ethiopia

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T15:23:04.039506+00:00

DOI: 10.1186/s12879-020-05615-1 · PMC7678206